Douglas Holtzman, Chief Scientific Officer at Icosavax, Inc. (ICVX), sold 40,586 shares at $6.08 ($247K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($247k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.08 | 20,143 | $122K | 49.6% |
| 2 | $6.08 | 20,143 | $122K | 49.6% |
| 3 | $6.56 | 300 | $2K | 0.8% |
| Total | $6.08 avg | 40,586 | $247K | 100% |
| Filing → |
| ICVX | SELL | 2022-12-16 | $438K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $131K | — | Filing → |